Strs Ohio Acquires Shares of 84,087 Intuitive Surgical, Inc. $ISRG

Key Points

• Strs Ohio has acquired a stake of 84,087 shares in Intuitive Surgical, valued at approximately $41.6 million, signaling strong institutional interest in the company.
• Wall Street analysts have shown positive sentiment, with the majority issuing a Buy rating and price targets ranging from $595 to $600, indicating expectations for growth.
• In recent insider transactions, executives sold significant shares, with total insider sales amounting to $21.7 million over the last quarter, which could raise questions about internal confidence in the stock's future performance.

Strs Ohio acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 84,087 shares of the medical equipment provider's stock, valued at approximately $41,646,000.

Other large investors have also recently made changes to their positions in the company. Brighton Jones LLC lifted its position in shares of Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after purchasing an additional 731 shares in the last quarter. Bank Pictet & Cie Europe AG boosted its holdings in Intuitive Surgical by 0.5% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock worth $99,678,000 after purchasing an additional 883 shares during the last quarter. Nomura Holdings Inc. boosted its holdings in Intuitive Surgical by 2.6% during the fourth quarter. Nomura Holdings Inc. now owns 37,541 shares of the medical equipment provider's stock worth $19,595,000 after purchasing an additional 936 shares during the last quarter. ProShare Advisors LLC boosted its holdings in Intuitive Surgical by 20.4% during the fourth quarter. ProShare Advisors LLC now owns 460,247 shares of the medical equipment provider's stock worth $240,231,000 after purchasing an additional 77,926 shares during the last quarter. Finally, Point72 Hong Kong Ltd boosted its holdings in Intuitive Surgical by 114.9% during the fourth quarter. Point72 Hong Kong Ltd now owns 19,230 shares of the medical equipment provider's stock worth $10,037,000 after purchasing an additional 10,280 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the stock. Erste Group Bank restated a "hold" rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Wall Street Zen upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Saturday, July 26th. Wells Fargo & Company boosted their price target on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a report on Wednesday, July 23rd. Piper Sandler restated an "overweight" rating and set a $595.00 price target (up from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, Truist Financial lifted their price objective on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. Thirteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $595.95.

Insider Transactions at Intuitive Surgical

In other news, Director Amy L. Ladd sold 336 shares of Intuitive Surgical stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares in the company, valued at $504,898.14. This trade represents a 23.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares of the company's stock, valued at approximately $173,845.44. This represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock worth $21,716,492 over the last quarter. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Up 1.3%

ISRG opened at $455.85 on Friday. The company has a market capitalization of $163.41 billion, a price-to-earnings ratio of 63.58, a PEG ratio of 4.72 and a beta of 1.61. The firm has a 50-day moving average price of $487.55 and a 200-day moving average price of $509.57. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping the consensus estimate of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company's revenue was up 21.4% on a year-over-year basis. During the same quarter last year, the company earned $1.78 earnings per share. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.